Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2021-11-24 00:00:00 ET · period of report 2021-11-23 · accession 0001171843-21-008176 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-24 | 2021-11-23 | BCRX | Doyle Anthony | CFO | P - Purchase | $12.48 | +35.3K | 93.7K | +60% | +$440.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-23 | P | A | 35,258 | $12.48 | 93,719 | D | — | — |